Dr. Amin Al Amiri, Assistant Undersecretary for Public Health Policy and Licenses at the Ministry of Health and Community Protection, said that the Ministry works side by side and cooperates with companies producing medicines not registered in the Ministry of Economy's patents in order to find appropriate solutions to this issue.
He pointed out that the ministry held several workshops and meetings last week, which included representatives of the ministries of health and the protection of society and economy, local factories and economic bodies, as well as an expert from the World Intellectual Property Organization (WIPO), during which the issue was discussed in various aspects and problems faced by manufacturers of non - As discussed many of the ideas, proposals and solutions that have not been announced and will be subject to research pending submission to the competent authorities concerned.
Dr. Amiri stressed the importance of tackling this issue because of its impact on the drug market in the UAE. He pointed out that the Ministry's extended hand to the companies that have not registered some of its drugs in the patent is in the interest of the human person in the first place. Companies from marketing their products domestically will lead to the loss of the local market for many new and innovative medicines needed by the UAE, which may be used in the treatment of some serious diseases. Therefore, the flow of these drugs must be maintained to the state and not to be expelled or obstructed. Of us.
It is noteworthy that a group of pharmaceutical companies did not register some of their products in the patent in the Ministry of Economy while registering with the Ministry of Health and Community Protection, working on the licenses obtained but does not have the exclusive distribution of medicines.